During liver regeneration quiescent differentiated hepatocytes replicate to restore the hepatic mass. Hepatocyte replication in the regenerating liver has a high degree of synchrony and involves the transcription and posttranscriptional activation of transcriptional factors, protooncogenes and growth factors among many other genes. In work supported by this grant (years 25-29) we demonstrated that cytokines are involved in the initiation of liver regeneration and that signaling through Tumor Necrosis Receptor type 1 (TNFR-1) required for liver regeneration by activating a pathway that includes NKkappaB, IL-6 and STAT3. Work in liver cell cultures developed in this laboratory as well as with RelA/TNFR-1 double knockout mice demonstrated that signaling through TNFR-1 can be proliferative, apoptotic or cause the transcription of acute phase response genes. This work led to the conclusion that hepatocytes need to be primed by cytokines to fully respond to the growth factors HGF and TFGalpha. However, major questions remain regarding the cytokine-dependent and independent mechanisms that initiate regeneration as well as the nature of signaling interactions between hepatocytes and Kupffer cells which may be required for hepatocyte replication. Furthermore, little information is available about mechanisms that may limit cytokine expression as well as DNA replication in the regenerating liver. We have designed experiments to address 4 specific questions using carefully selected mouse models and hepatocyte cell cultures: a) whether blockage of NFkappaB activation in hepatocytes but not in Kupffer cells will interfere with liver regeneration; b) whether the blockage of the generation of Reactive Oxygen Species (ROS) inhibits hepatocyte DNA replication; c) whether LPS is responsible for TNF induction at the start of liver regeneration; d) whether 2 distinct negative feedback mechanisms acting on cytokine signaling and MAP kinase activity may respectively regulate the initiation and cell cycle progression phases of liver regeneration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA023226-32
Application #
6628218
Study Section
Pathology B Study Section (PTHB)
Program Officer
Spalholz, Barbara A
Project Start
1977-08-01
Project End
2006-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
32
Fiscal Year
2003
Total Cost
$376,485
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wright, Jocelyn H; Johnson, Melissa M; Shimizu-Albergine, Masami et al. (2014) Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer 134:778-88
Riehle, Kimberly J; Johnson, Melissa M; Johansson, Fredrik et al. (2014) Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation. Biochim Biophys Acta 1842:318-25
Obayashi, Yoko; Campbell, Jean S; Fausto, Nelson et al. (2013) Impaired lipid accumulation in the liver of Tsc2-heterozygous mice during liver regeneration. Biochem Biophys Res Commun 437:146-50
Riehle, Kimberly J; Haque, Jamil; McMahan, Ryan S et al. (2013) Sustained Glutathione Deficiency Interferes with the Liver Response to TNF-? and Liver Regeneration after Partial Hepatectomy in Mice. J Liver Disease Transplant 1:
McMahan, Ryan S; Riehle, Kimberly J; Fausto, Nelson et al. (2013) A disintegrin and metalloproteinase 17 regulates TNF and TNFR1 levels in inflammation and liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol 305:G25-34
Fernando, Joan; Sancho, Patricia; Fernandez-Rodriguez, Conrado M et al. (2012) Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. J Cell Physiol 227:1319-25
Okada, Hikari; Honda, Masao; Campbell, Jean S et al. (2012) Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res 72:4459-71
Caja, Laia; Bertran, Esther; Campbell, Jean et al. (2011) The transforming growth factor-beta (TGF-?) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J Cell Physiol 226:1214-23
Riehle, Kimberly J; Dan, Yock Y; Campbell, Jean S et al. (2011) New concepts in liver regeneration. J Gastroenterol Hepatol 26 Suppl 1:203-12
Caja, Laia; Sancho, Patricia; Bertran, Esther et al. (2011) The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms. Biochem Pharmacol 82:1583-92

Showing the most recent 10 out of 85 publications